Genetic profiling versus drug rotation in the optimisation of antihypertensive treatment

Author： Mackenzie Isla S   Brown Morris J  

Publisher： Royal College Of Physicians

ISSN： 1470-2118

Source： Clinical Medicine, Vol.2, Iss.5, 2002-09, pp. : 465-473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Milestones in Antihypertensive Drug Treatment

By  

Current Pharmaceutical Design, Vol. 21, Iss. 6, 2015-02 ,pp. : 705-708

Bentham Science Publishers

Access to resources Recommend Favorite

Combination Treatment in Antihypertensive Drug Trials

By Mancia Giuseppe   Grassi Guido  

Cardiovascular Drugs and Therapy, Vol. 11, Iss. 4, 1997-09 ,pp. : 517-518

Springer Publishing Company

Access to resources Recommend Favorite

Drug-Gene Interactions between Genetic Polymorphisms and Antihypertensive Therapy

By Hedi Schelleman   Bruno H. Ch. Stricker  

Drugs, Vol. 64, Iss. 16, 2004-01 ,pp. : 1801-1816

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of Antihypertensive Drug Responses

By Schwartz G.L.   Turner S.T.  

American Journal of PharmacoGenomics, Vol. 4, Iss. 3, 2004-01 ,pp. : 151-160

Adis International

Access to resources Recommend Favorite

Optimisation of Treatment by Applying Programmable Rate-Controlled Drug Delivery Technology

By Chien Y.W.  

Clinical Pharmacokinetics, Vol. 41, Iss. 15, 2002-01 ,pp. : 1267-1299

Adis International

Access to resources Recommend Favorite